Top Markets
Coin of the day
OptiNose, Inc. OptiNose, Inc.

OptiNose, Inc.

OPTN
Classement en actions #9145
OptiNose, Inc. is a specialized pharmaceutical company primarily focused on... OptiNose, Inc. is a specialized pharmaceutical company primarily focused on innovating and bringing to market treatments for individuals under the care of ear, nose, throat, and allergy specialists throughout the United States. Its flagship product, XHANCE, utilizes the company's proprietary exhalation delivery system (EDS) to administer a topically-acting corticosteroid. This therapy is approved for treating chronic rhinosinusitis when accompanied by nasal polyps and is currently undergoing Phase IIIb clinical trials for broader chronic sinusitis treatment. The company also offers Onzetra Xsail, a powder-based EDS device, which is commercialized via a licensing agreement with Currax Pharmaceuticals LLC. Further expanding its pipeline, OptiNose is developing OPN-019, an investigational product that integrates a liquid EDS device with an antiseptic agent. Additionally, OptiNose has formed a partnership with Inexia Limited. This collaboration centers on the development, manufacturing, importation, and sale of products containing orexin receptor agonist or positive modulator molecules, intended for the treatment, diagnosis, or prevention of human conditions predominantly linked to orexin receptor activity. Established in 2000, OptiNose, Inc. operates from its corporate headquarters in Yardley, Pennsylvania.
Prix de l'action
$9.60
Dernière synchronisation: 2025-05-21
Capitalisation boursière
$1.08B
Changement (1 jour)
0.00%
Changement (1 an)
0.00%
Pays
US
Échange OptiNose, Inc. (OPTN)

Catégorie

EPS pour OptiNose, Inc. (OPTN)
EPS au March 2025 TTM : $-2.67
Selon les derniers rapports financiers et le cours de l'action de OptiNose, Inc., l’EPS actuel de la société (TTM) est de $-2.67. À la fin de 2023, la société avait un EPS de $-0.32 une diminution par rapport à celui de 2022, qui était de $-13.05.
Historique de l'EPS de OptiNose, Inc. de 2015 à 2026
EPS à la fin de chaque année
Année EPS Changez
2026 (TTM) $-2.67 25.94%
2024 $-2.12 562.50%
2023 $-0.32 -97.55%
2022 $-13.05 806.25%
2021 $-1.44 -29.41%
2020 $-2.04 -21.54%
2019 $-2.60 -2.99%
2018 $-2.68 83.56%
2017 $-1.46 -505.56%
2016 $0.36 -108.39%
2015 $-4.29 0.00%
EPS pour des entreprises ou concurrents similaires